Results 21 to 30 of about 23,474 (233)

Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review

Diabetes, Metabolic Syndrome and Obesity, 2022
Sarah Dahlberg,1 Ellen T Chang,1 Sheila R Weiss,1 Pamela Dopart,1 Errol Gould,2 Mary E Ritchey3 1Exponent, Inc, Menlo Park, CA, 94025, USA; 2Currax Pharmaceuticals LLC., Brentwood, TN, 37027, USA; 3Med Tech Epi, LLC., Philadelphia, PA, 19147 ...
Dahlberg S, Chang ET, Weiss SR, Dopart P, Gould E, Ritchey ME   +5 more
doaj  

Desipramin, Venlafaksin ve Bupropionun Farelerdeki Depresyon ve Anksiyete Üzerine Etkilerinin Zorunlu Yüzme Testi ve Yükseltilmiş Artı Labirent Testi ile Değerlendirilmesi

Sakarya Tıp Dergisi, 2018
Bu çalışmada, farelerde desipramin, venlafaksin ve bupropiyonun depresyon ve anksiyete üzerine etkilerini araştırmayı amaçladık. Klasik trisiklik antidepresan, desipramin, serotonin-norepinefrin geri alım inhibitörü venlafaksin ve ikinci jenerasyon ...
Mehmet Emin Büyükokuroğlu, Pelin Tanyeri, Oğuz Mutlu, Güner Ulak, Mehmet Hanifi Tanyeri, Bekir Faruk Erden, Füruzan Akar   +6 more
doaj   +1 more source

Prediction of Drug-Drug Interactions with Bupropion and Its Metabolites as CYP2D6 Inhibitors Using a Physiologically-Based Pharmacokinetic Model

Pharmaceutics, 2017
The potential of inhibitory metabolites of perpetrator drugs to contribute to drug-drug interactions (DDIs) is uncommon and underestimated. However, the occurrence of unexpected DDI suggests the potential contribution of metabolites to the observed DDI ...
Caifu Xue, Xunjie Zhang, Weimin Cai
doaj   +1 more source

The association of COMT genotype with buproprion treatment response in the treatment of major depressive disorder

Brain and Behavior, 2020
Background Pharmacodynamics and pharmacogenetics are being explored in pharmacological treatment response for major depressive disorder (MDD). Interactions between genotype and treatment response may be dose dependent.
Jay Fawver, Mindy Flanagan, Thomas Smith, Michelle Drouin, Michael Mirro   +4 more
doaj   +1 more source

Peptic Ulcer Disease Following Use of Bupropion: A Case Report

Clinical Medicine Insights: Case Reports, 2023
Background: Bupropion is a dopamine reuptake inhibitor, which is prescribed as an effective drug for the treatment of depression and as a complementary drug for smoking cessation in more than 50 countries.
Zahra Momayez Sanat, Negar Mohammadi Ganjaroudi, Ali Pirsalehi   +2 more
doaj   +1 more source

Galactorrhoea as a side effect due to Bupropion- a case report

European Psychiatry, 2021
Introduction Bupropion is a NDRI antidepressant with action on both serotonin and nicotinic receptors. Endocrine and sexual adverse effects are very rare and hence very unlikely to cause hyperprolactinemia.
D. Bhandutia, S. Nayok
doaj   +1 more source

Bupropion perceived as a stimulant by two patients with a previous history of cocaine misuse

Annali dell'Istituto Superiore di Sanità, 2013
BACKGROUND AND OBJECTIVE: Despite animal studies having shown a generalisation of the bupropion cue to cocaine, this drug has been used in cocaine abuse with mixed results. We here aimed at describing two cases which contradict current knowledge.
Alessandro E. Vento, Fabrizio Schifano, Federica Gentili, Francesco Pompei, John M. Corkery, Georgios D. Kotzalidis, Paolo Girardi   +6 more
doaj   +1 more source

The role of the endoplasmic reticulum in the metabolism of "xenobiotica" [PDF]

, 2013
Short-chain dehydrogenase/reductase (SDR) enzymes play a key role in the metabolism of steroids, fatty acids, prostaglandins and xenobiotic chemicals.
Meyer, Arne
core   +1 more source

Effectiveness of bupropion on sexual dysfunction of women with multiple sclerosis: A Clinical Trial [PDF]

Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2021
Introduction: Sexual dysfunctions are relatively prevalent in female patients with multiple sclerosis (MS) and affect their quality of life. This study was performed with aim to evaluate the effect of Bupropion on sexual function in women with multiple ...
Farzaneh Yavari, Mehrdad Salehi, Omid Mirmosayyeb, Mohammad Javad Tarrahi, Majid barekatain, Vahid Shaygannejad, Fereshteh Ashtari, Mitra Mollaeinezhad   +7 more
doaj   +1 more source

Bupropion and Naltrexone in Methamphetamine Use Disorder [PDF]

, 2021
BACKGROUND: The use of naltrexone plus bupropion to treat methamphetamine use disorder has not been well studied. METHODS: We conducted this multisite, double-blind, two-stage, placebo-controlled trial with the use of a sequential parallel comparison ...
Bart, Gavin, Sonne, Susan C, Carmody, Thomas, Wiest, Katharina, Trivedi, Madhukar H, Shores-Wilson, Kathy, Coffin, Phillip, Wakhlu, Sidarth, Sharma, Gaurav, Sparenborg, Steven, Ling, Walter, Rush, A John, Ghitza, Udi E, Kim, Mora, Walker, Robrina, Schmitz, Joy, Shoptaw, Steven, Nunes, Edward V, Dela Cruz, Adriane, Wahle, Aimee   +19 more
core   +1 more source